Purine and purinergic receptors
Open accessThe DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Abstract
Adenosine 5′-triphosphate acts as an extracellular signalling molecule (purinergic signalling), as well as an intracellular energy source. Adenosine 5′-triphosphate receptors have been cloned and characterised. P1 receptors are selective for adenosine, a breakdown product of adenosine 5′-triphosphate after degradation by ectonucleotidases. Four subtypes are recognised, A 1, A 2A, A 2B and A 3 receptors. P2 receptors are activated by purine and by pyrimidine nucleotides. P2X receptors are ligand-gated ion channel receptors (seven subunits (P2X1-7)), which form trimers as both homomultimers and heteromultimers. P2Y receptors are G protein-coupled receptors (eight subtypes (P2Y 1/2/4/6/11/12/13/14)). There is both purinergic short-term signalling and long-term (trophic) signalling. The cloning of P2X-like receptors in primitive invertebrates suggests that adenosine 5′-triphosphate is an early evolutionary extracellular signalling molecule. Selective purinoceptor agonists and antagonists with therapeutic potential have been developed for a wide range of diseases, including thrombosis and stroke, dry eye, atherosclerosis, kidney failure, osteoporosis, bladder incontinence, colitis, neurodegenerative diseases and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
(1909) · Journal of the American Medical Association · doi:10.1001/jama.1909.02550020033007 · Cited by 7,866
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Purinergic Signalling and the Nervous System · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,958
Self-citationMolecular Physiology of P2X Receptors
North, R. A. (2002) · Physiological Reviews · doi:10.1152/physrev.00015.2002 · Cited by 2,919 · cited 5×
“The stoichiometry of P2X1-7 receptors involves three subunits, which form a stretched trimer or a hexamer of conjoined trimers (Nicke et al., 1998; North, 2002; Stelmashenko et al., 2012).”
BackgroundInfluential(2024) · Pharmacological Reviews · doi:10.1124/pr · Cited by 2,664
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585
Burnstock, G. (1972) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06930-3 · Cited by 1,852
Self-citationThe Cytolytic P 2Z Receptor for Extracellular ATP Identified as a P 2X Receptor (P2X 7 )
Surprenant, A., Rassendren, F., Kawashima, E., North, R. A., & Buell, G. (1996) · Science · doi:10.1126/science.272.5262.735 · Cited by 1,739 · cited 1×
“Full-length cDNAs were later isolated from a rat brain cDNA library (Surprenant et al., 1996).”
BackgroundPhysiology and Pathophysiology of Purinergic Neurotransmission
Burnstock, G. (2007) · Physiological Reviews · doi:10.1152/physrev.00043.2006 · Cited by 1,585
Self-citationDrury, A. N., & Szent-Györgyi, A. (1929) · The Journal of Physiology · doi:10.1113/jphysiol.1929.sp002608 · Cited by 1,487
Identification of the platelet ADP receptor targeted by antithrombotic drugs
Hollopeter, G., Jantzen, H.-M., Vincent, D., Li, G., England, L., Ramakrishnan, V., Yang, R.-B., Nurden, P., Nurden, A., Julius, D., et al. (2001) · Nature · doi:10.1038/35051599 · Cited by 1,423
Calker, D. V., Müller, M., & Hamprecht, B. (1979) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1979.tb05236.x · Cited by 1,371
Is there a basis for distinguishing two types of P2-purinoceptor?
Burnstock, G., & Kennedy, C. (1985) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(85)90001-1 · Cited by 1,365
Self-citationAbbracchio, M. P., Burnstock, G., Boeynaems, J.-M., Barnard, E. A., Boyer, J. L., Kennedy, C., Knight, G. E., Fumagalli, M., Gachet, C., Jacobson, K. A., et al. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.3 · Cited by 1,281
Self-citationYegutkin, G. G. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.01.024 · Cited by 1,154
Purinoceptors: Are there families of P2X and P2Y purinoceptors?
Abbracchio, M. P., & Burnstock, G. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)00048-4 · Cited by 1,083
Self-citationSubclasses of external adenosine receptors.
Londos, C., Cooper, D. M., & Wolff, J. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.2551 · Cited by 1,081
Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice
Cockayne, D. A., Hamilton, S. G., Zhu, Q.-M., Dunn, P. M., Zhong, Y., Novakovic, S., Malmberg, A. B., Cain, G., Berson, A., Kassotakis, L., et al. (2000) · Nature · doi:10.1038/35039519 · Cited by 1,030
Self-citationA new class of ligand-gated ion channel defined by P2X receptor for extracellular ATP
Valera, S., Hussy, N., Evans, R. J., Adami, N., North, R. A., Surprenant, A., & Buell, G. (1994) · Nature · doi:10.1038/371516a0 · Cited by 1,029
A P2X purinoceptor expressed by a subset of sensory neurons
Chen, C.-C., Akopian, A. N., Sivilottit, L., Colquhoun, D., Burnstock, G., & Wood, J. N. (1995) · Nature · doi:10.1038/377428a0 · Cited by 1,016
Self-citationLewis, C., Neidhart, S., Holy, C., North, R. A., Buell, G., & Surprenant, A. (1995) · Nature · doi:10.1038/377432a0 · Cited by 997
New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor
Brake, A. J., Wagenbach, M. J., & Julius, D. (1994) · Nature · doi:10.1038/371519a0 · Cited by 919
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor
Ledent, C., Vaugeois, J.-M., Schiffmann, S. N., Pedrazzini, T., Yacoubi, M. E., Vanderhaeghen, J.-J., Costentin, J., Heath, J. K., Vassart, G., & Parmentier, M. (1997) · Nature · doi:10.1038/41771 · Cited by 918
Hoult, R. (1979) · FEBS Letters · doi:10.1016/0014-5793(79)81367-8 · Cited by 855
Cellular Distribution and Functions of P2 Receptor Subtypes in Different Systems
Burnstock, G., & Knight, G. E. (2004) · International Review of Cytology · doi:10.1016/s0074-7696(04)40002-3 · Cited by 795
Self-citationThe Kidney: Physiology and Pathophysiology.
(1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-5-821_1 · Cited by 754
Crystal structure of the ATP-gated P2X4 ion channel in the closed state
Kawate, T., Michel, J. C., Birdsong, W. T., & Gouaux, E. (2009) · Nature · doi:10.1038/nature08198 · Cited by 738
Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.
Zhou, Q. Y., Li, C., Olah, M. E., Johnson, R. A., Stiles, G. L., & Civelli, O. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7432 · Cited by 658
Selective Amplification And Cloning Of Four New Members Of The G Protein-coupled Receptor Family
Libert, F., Parmentier, M., Lefort, A., Dinsart, C., Van Sande, J., Maenhaut, C., Simons, M.-J., Dumont, J. E., & Vassart, G. (1989) · Science · doi:10.1126/science.2541503 · Cited by 641
Purinergic signalling and disorders of the central nervous system
Burnstock, G. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2605 · Cited by 634
Self-citationPathophysiology and Therapeutic Potential of Purinergic Signaling
Burnstock, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.5 · Cited by 611
Self-citationExpression cloning of an ATP receptor from mouse neuroblastoma cells.
Lustig, K. D., Shiau, A. K., Brake, A. J., & Julius, D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5113 · Cited by 594
Extracellular adenosine triphosphate and adenosine in cancer
Stagg, J., & Smyth, M. J. (2010) · Oncogene · doi:10.1038/onc.2010.292 · Cited by 571
P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels
Nicke, A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3016 · Cited by 554
Cloning and functional expression of a brain G‐protein‐coupled ATP receptor
Webb, T. E., Simon, J., Krishek, B. J., Bateson, A. N., Smart, T. G., King, B. F., Burnstock, G., & Barnard, E. A. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81397-i · Cited by 548
Self-citationPurinergic Signalling: ATP Release
Bodin, P., & Burnstock, G. (2001) · Neurochemical Research · doi:10.1023/a:1012388618693 · Cited by 521
Self-citationBradbury, E. J., Burnstock, G., & McMahon, S. B. (1998) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1998.0719 · Cited by 466
Self-citationP2X3Knock-Out Mice Reveal a Major Sensory Role for Urothelially Released ATP
Vlaskovska, M., Kasakov, L., Rong, W., Bodin, P., Bardini, M., Cockayne, D. A., Ford, A. P. D. W., & Burnstock, G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05670.2001 · Cited by 465
Self-citationPurinergic Signalling: Pathophysiological Roles
Maria P., A., & Geoffrey, B. (1998) · Japanese Journal of Pharmacology · doi:10.1254/jjp.78.113 · Cited by 444
Hetero-oligomeric Assembly of P2X Receptor Subunits
Torres, G. E., Egan, T. M., & Voigt, M. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6653 · Cited by 414
Purinergic Signaling and Vascular Cell Proliferation and Death
Burnstock, G. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0302.105360 · Cited by 414
Self-citationAbbracchio, M. P., Boeynaems, J.-M., Barnard, E. A., Boyer, J. L., Kennedy, C., Miras-Portugal, M. T., King, B. F., Gachet, C., Jacobson, K. A., Weisman, G. A., et al. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)00038-x · Cited by 413
Self-citationSun, D., Samuelson, L. C., Yang, T., Huang, Y., Paliege, A., Saunders, T., Briggs, J., & Schnermann, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171317998 · Cited by 404
Purinergic signalling: From normal behaviour to pathological brain function
Burnstock, G., Krügel, U., Abbracchio, M. P., & Illes, P. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.006 · Cited by 397
Self-citationThe P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in Models of Disease
Bartlett, R., Stokes, L., & Sluyter, R. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008003 · Cited by 393
P2X7 receptor: an emerging target in central nervous system diseases
Sperlágh, B., & Illes, P. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.08.002 · Cited by 390 · cited 1×
“There is increasing attention to the potential roles of purinergic signalling in trauma, ischaemia and neurodegenerative conditions, including Alzheimer’s, Parkinson’s and Huntington’s diseases, multiple sclerosis and amyotrophic lateral sclerosis (Burnstock, 2007; Sperlágh and Illes, 2014).”
BackgroundBURNSTOCK, G. (1999) · Journal of Anatomy · doi:10.1046/j.1469-7580.1999.19430335.x · Cited by 355
Self-citationP2 receptors in cardiovascular regulation and disease
Erlinge, D., & Burnstock, G. (2008) · Purinergic Signalling · doi:10.1007/s11302-007-9078-7 · Cited by 344
Self-citationA G Protein-coupled Receptor for UDP-glucose
Chambers, J. K., Macdonald, L. E., Sarau, H. M., Ames, R. S., Freeman, K., Foley, J. J., Zhu, Y., McLaughlin, M. M., Murdock, P., McMillan, L., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.10767 · Cited by 342
Identification of a Novel Human ADP Receptor Coupled to Gi
Communi, D., Gonzalez, N. S., Detheux, M., Brézillon, S., Lannoy, V., Parmentier, M., & Boeynaems, J.-M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105912200 · Cited by 334
Savi, P., & Herbert, J.-M. (2005) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2005-869523 · Cited by 327
Purinergic signalling and cancer
Burnstock, G., & Di Virgilio, F. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9372-5 · Cited by 316
Self-citationAllosteric Control of Gating and Kinetics at P2X4Receptor Channels
Khakh, B. S., Proctor, W. R., Dunwiddie, T. V., Labarca, C., & Lester, H. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-17-07289.1999 · Cited by 279
A P2X purinoceptor cDNA conferring a novel pharmacological profile
Bo, X., Zhang, Y., Nassar, M., Burnstock, G., & Schoepfer, R. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01203-q · Cited by 278
Self-citationAdenosine 5′-Triphosphate: a P2-Purinergic Agonist in the Myocardium
Vassort, G. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.767 · Cited by 276
P2X Receptors: An Emerging Channel Family
Buell, G., Collo, G., & Rassendren, F. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb00745.x · Cited by 259
White, N., & Burnstock, G. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.02.004 · Cited by 251
Self-citationA unifying purinergic hypothesis for the initiation of pain
Burnstock, G. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91082-x · Cited by 239
Self-citationPurinergic signalling: Its unpopular beginning, its acceptance and its exciting future
Burnstock, G. (2012) · BioEssays · doi:10.1002/bies.201100130 · Cited by 209
Self-citationBurnstock, G. (1976) · Journal of Theoretical Biology · doi:10.1016/0022-5193(76)90133-8 · Cited by 207
Self-citationMolecular cloning and characterization of rat P2Y4 nucleotide receptor
Bogdanov, Y. D., Wildman, S. S., Clements, M. P., King, B. F., & Burnstock, G. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701880 · Cited by 201
Self-citationBurnstock, G., & Verkhratsky, A. (2010) · Cell Death & Disease · doi:10.1038/cddis.2009.11 · Cited by 197
Self-citationBurnstock, G. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788186335 · Cited by 195
Self-citationCressman, V. L., Lazarowski, E., Homolya, L., Boucher, R. C., Koller, B. H., & Grubb, B. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.26461 · Cited by 186
Verkhratsky, A., & Burnstock, G. (2014) · BioEssays · doi:10.1002/bies.201400024 · Cited by 182
Self-citationMolecular properties of P2X receptors
Roberts, J. A., Vial, C., Digby, H. R., Agboh, K. C., Wen, H., Atterbury-Thomas, A., & Evans, R. J. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0073-6 · Cited by 175
Extracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infection
Séror, C., Melki, M.-T., Subra, F., Raza, S. Q., Bras, M., Saïdi, H., Nardacci, R., Voisin, L., Paoletti, A., Law, F., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101805 · Cited by 170
Coexpression of Rat P2X2and P2X6Subunits inXenopusOocytes
King, B. F., Townsend‐Nicholson, A., Wildman, S. S. P., Thomas, T., Spyer, K. M., & Burnstock, G. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-13-04871.2000 · Cited by 160
Self-citationPurinergic signalling and bone remodelling☆
Orriss, I. R., Burnstock, G., & Arnett, T. R. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.01.003 · Cited by 154
Self-citationMolecular Mechanisms of Purine and Pyrimidine Nucleotide Release
Lazarowski, E. R., Sesma, J. I., Seminario‐Vidal, L., & Kreda, S. M. (2011) · Advances in pharmacology · doi:10.1016/b978-0-12-385526-8.00008-4 · Cited by 151
Purinergic mechanisms and pain—An update
Burnstock, G. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.078 · Cited by 141
Self-citationPurinergic signaling in embryonic and stem cell development
Burnstock, G., & Ulrich, H. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0614-1 · Cited by 136
Self-citationEarly Expression of a Novel Nucleotide Receptor in the Neural Plate of Xenopus Embryos
Bogdanov, Y. D., Dale, L., King, B. F., Whittock, N. V., & Burnstock, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.19.12583 · Cited by 135
Self-citationP2X7 Deficiency Attenuates Renal Injury in Experimental Glomerulonephritis
Taylor, S. R. J., Turner, C. M., Elliott, J. I., McDaid, J., Hewitt, R., Smith, J., Pickering, M. C., Whitehouse, D. L., Cook, H. T., Burnstock, G., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008060559 · Cited by 127
Self-citationMolecular cloning and functional expression of a novel rat heart P2X purinoceptor
García‐Guzmán, M., Soto, F., Laube, B., & Stühmer, W. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00499-1 · Cited by 125
Novel perspectives of neural stem cell differentiation: From neurotransmitters to therapeutics
Trujillo, C. A., Schwindt, T. T., Martins, A. H. B., Alves, J. M., Mello, L. E., & Ulrich, H. (2008) · Cytometry Part A · doi:10.1002/cyto.a.20666 · Cited by 121
Hoebertz, A., Mahendran, S., Burnstock, G., & Arnett, T. R. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10236 · Cited by 112
Self-citationCloning and Tissue Distribution of a Novel P2X Receptor from Rat Brain
Soto, F., García‐Guzmán, M., Karschin, C., & Stühmer, W. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0915 · Cited by 109
Biochemical and functional evidence for heteromeric assembly of P2X1 and P2X4 subunits
Nicke, A., Kerschensteiner, D., & Soto, F. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02939.x · Cited by 109
Molecular characterization and pharmacological properties of the human P2X3 purinoceptor
García‐Guzmán, M., Stühmer, W., & Soto, F. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00036-3 · Cited by 108
Molecular and Functional Characterization of Human P2X 2 Receptors
Lynch, K. J., Touma, E., Niforatos, W., Kage, K., Burgard, E. C., van Biesen, T., Kowaluk, E. A., & Jarvis, M. F. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.6.1171 · Cited by 95
Surprenant, A., Schneider, D. A., Wilson, H. L., Galligan, J. J., & North, R. A. (2000) · Journal of the Autonomic Nervous System · doi:10.1016/s0165-1838(00)00123-5 · Cited by 93
Loss of Nucleotide Regulation of Epithelial Chloride Transport in the Jejunum of P2Y4-Null Mice
Robaye, B., Ghanem, E., Wilkin, F., Fokan, D., Driessche, W. V., Schurmans, S., Boeynaems, J., & Beauwens, R. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.4.777 · Cited by 92
Hetero‐oligomerization of adenosine A1 receptors with P2Y1 receptors in rat brains
Yoshioka, K., Hosoda, R., Kuroda, Y., & Nakata, H. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03540-8 · Cited by 91
P2X2 and P2X5 Subunits Define a New Heteromeric Receptor with P2X7-Like Properties
Compan, V., Ulmann, L., Stelmashenko, O., Chemin, J., Chaumont‐Dubel, S., & Rassendren, F. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6332-11.2012 · Cited by 89
Heteromultimeric P2X1/2 Receptors Show a Novel Sensitivity to Extracellular pH
Brown, S. G., Townsend‐Nicholson, A., Jacobson, K. A., Burnstock, G., & King, B. F. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.2.673 · Cited by 86
Self-citationInhaled P2Y2 receptor agonists as a treatment for patients with Cystic Fibrosis lung disease
Kellerman, D., Evans, R., Mathews, D., & Shaffer, C. L. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00154-0 · Cited by 79
Purinergic Signalling in Lower Urinary Tract
Burnstock, G. (2001) · Springer eBooks · doi:10.1007/978-3-662-09604-8_15 · Cited by 79
Self-citationTherapeutic potential of purinergic signalling for diseases of the urinary tract
Burnstock, G. (2011) · British Journal of Urology · doi:10.1111/j.1464-410x.2010.09926.x · Cited by 76
Self-citationParravicini, C., Ranghino, G., Abbracchio, M. P., & Fantucci, P. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-263 · Cited by 75
Bo, X., Schoepfer, R., & Burnstock, G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14401 · Cited by 73
Self-citationImmunohistochemical localization of the P2Y1 purinergic receptor in Alzheimerʼs disease
Moore, D. J., Iritani, S., Chambers, J. K., & Emson, P. C. (2000) · Neuroreport · doi:10.1097/00001756-200011270-00041 · Cited by 72
An in vivo model of melanoma: treatment with ATP
White, N., Knight, G. E., Butler, P. E. M., & Burnstock, G. (2009) · Purinergic Signalling · doi:10.1007/s11302-009-9156-0 · Cited by 68
Self-citationInoue, K. (2007) · Purinergic Signalling · doi:10.1007/s11302-006-9045-8 · Cited by 64
Ryten, M., Yang, S. Y., Dunn, P. M., Goldspink, G., & Burnstock, G. (2004) · The FASEB Journal · doi:10.1096/fj.03-1175fje · Cited by 63
Self-citationHou, M., Möller, S., Edvinsson, L. I., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.9.2064 · Cited by 62
Activation of ureter nociceptors by exogenous and endogenous ATP in guinea pig
Rong, W., & Burnstock, G. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.08.003 · Cited by 57
Self-citationPurinergic receptor‐mediated effects of adenosine 5′‐triphosphate in urological malignant diseases
Shabbir, M., & Burnstock, G. (2008) · International Journal of Urology · doi:10.1111/j.1442-2042.2008.02207.x · Cited by 55
Self-citationActivation of Trimeric P2X2 Receptors by Fewer than Three ATP Molecules
Stelmashenko, O., Lalo, U., Yue, Y., Bragg, L., North, R. A., & Compan, V. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.080903 · Cited by 55
Effect of extracellular ATP on the growth of hormone‐refractory prostate cancer in vivo
Shabbir, M., Thompson, C., Jarmulowiczc, M., Mikhailidis, D., & Burnstock, G. (2008) · BJU International · doi:10.1111/j.1464-410x.2008.07578.x · Cited by 54
Self-citationKumral, A., Tüzün, F., Yeşilırmak, D. C., Duman, N., & Özkan, H. (2012) · Acta Paediatrica · doi:10.1111/j.1651-2227.2012.02664.x · Cited by 52
Caseley, E., Muench, S., Roger, S., Mao, H.-J., Baldwin, S., & Jiang, L.-H. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150813344 · Cited by 51
Inhibition of potassium and calcium currents in neurones by molecularly-defined P2Y receptors
Brown, D. A., Filippov, A. K., & Barnard, E. A. (2000) · Journal of the Autonomic Nervous System · doi:10.1016/s0165-1838(00)00150-8 · Cited by 44
Purinergic receptors as future targets for treatment of functional GI disorders
Burnstock, G. (2008) · Gut · doi:10.1136/gut.2008.151134 · Cited by 43
Self-citationTwo open states of P2X receptor channels
Rokic, M. B., & Stojilković, S. S. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fncel.2013.00215 · Cited by 40
Egan, T. M., Cox, J. A., & Voigt, M. M. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01685-9 · Cited by 37
Structural and Molecular Modeling Features of P2X Receptors
Alves, L. A., Silva, J. D., Ferreira, D. N. M., Fidalgo-Neto, A. A., Teixeira, P., Souza, C. D., Caffarena, E. R., & Freitas, M. D. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034531 · Cited by 32
Delic, J., & Zimmermann, H. (2010) · Purinergic Signalling · doi:10.1007/s11302-010-9206-7 · Cited by 31
Cited by
From purines to purinergic signalling: molecular functions and human diseases
Huang, Z., Xie, N., Illes, P., Di Virgilio, F., Ulrich, H., Semyanov, A., Verkhratsky, A., Sperlagh, B., Yu, S.-G., Huang, C., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00553-z · Cited by 489
Energy metabolism in health and diseases
Liu, H., Wang, S., Wang, J., Guo, X., Song, Y., Fu, K., Gao, Z., Liu, D., He, W., & Yang, L.-L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02141-x · Cited by 399
How microglia sense and regulate neuronal activity
Umpierre, A. D., & Wu, L. (2021) · Glia · doi:10.1002/glia.23961 · Cited by 237
Microglia and Neuroinflammation: What Place for P2RY12?
Gómez Morillas, A., Besson, V. C., & Lerouet, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041636 · Cited by 214
“The purinergic receptor family is divided into two subfamilies, P1 and P2 receptors, depending on their endogenous agonists [4,5].”
BackgroundRole of P2X7 Receptors in Immune Responses During Neurodegeneration
Oliveira-Giacomelli, Á., Petiz, L. L., Andrejew, R., Turrini, N., Silva, J. B., Sack, U., & Ulrich, H. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.662935 · Cited by 68
“P2 receptors are further divided into P2Y (metabotropic) and P2X (ionotropic) receptors, which include the P2X7 receptor (Burnstock, 2018), composed of two transmembrane domains and assembled as trimeric receptors.”
Background
Metadata
- Authors
- Burnstock, G.
- Venue
- Brain and Neuroscience Advances
- Publisher
- SAGE Publications
- Published
- 2018-01
- Volume
- 2
- Pages
- 2398212818817494-2398212818817494
- ISSN
- 2398-2128 (ISSN-L)
- OpenAlex
- W2905070817
- Cited by
- 329
- References
- 107
- FWCI
- 16.21
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.